Australia's system of HTA decision-making can be imagined as a scramble of one hundred eggs. For the therapies and other technologies that provide better patient outcomes, the review's report proposes adding more eggs to the scramble. For therapies that can deliver savings, the scramble is discarded. …
The HTA Review report - 'Red Flag' number two of five
September 16, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The Dispatched 'Week in Review' Podcast - 3 October
October 3, 2025 - - Podcast -
The challenge is for our gatekeepers. Can they see beyond the gate?
October 3, 2025 - - Latest News -
Trump administration links MFN and lower prices to faster FDA approvals
October 3, 2025 - - Latest News -
Vertex appoints Elisha Whitfield as senior country manager for Australia and New Zealand
October 2, 2025 - - Latest News -
Race Oncology uncovers novel anticancer mechanism for bisantrene
October 2, 2025 - - Australian Biotech -
Mark Butler announces boost for clinical trial reform, after years of delay
October 2, 2025 - - Latest News -
Pharmac moves to ease access to HIV medicines in New Zealand
October 2, 2025 - - Latest News